Almac Receives NY Lab Permit for Trial Enrichment and Companion Diagnostics Development - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Almac Receives NY Lab Permit for Trial Enrichment and Companion Diagnostics Development

Source: Applied Clinical Trials

Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing Almac's Craigavon, UK-based lab to receive patient samples for clinical testing from New York. Almac has also successfully retained its CAP and CLIA accreditation following an inspection by the College of American Pathologists (CAP).

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here